Healthy Skepticism Library item: 10574

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Cassell GH.
Interactions of the public and private sectors in drug development: boundaries to protect scientific values while preserving innovation.
Cleve Clin J Med 2007 Mar; 74:
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17469473&dopt=Abstract

Abstract:

Industry, academia, and government have developed highly interwoven relationships in the pursuit of biomedical research. Establishing and maintaining boundaries among the public and private sectors at both the institutional level and the individual level is critical to protect core scientific values, preserve innovation, and allow product development to thrive. This article reviews principles that guide the interactions of these Biomdifferent sectors, sharing principles in place at Eli Lilly and Company as an example.

Keywords:
MeSH Terms: Academic Medical Centers/economics Academic Medical Centers/ethics* Alabama Biomedical Research/ethics* Conflict of Interest* Cooperative Behavior Diffusion of Innovation Drug Evaluation/economics Drug Evaluation/ethics* Drug Industry/ethics* Government Regulation Humans Private Sector/ethics Public Sector/ethics Scientific Misconduct* United States